Picard Medical, Inc.

1 known investors

Picard Medical is the parent company of SynCardia Systems, which develops and commercializes the SynCardia Total Artificial Heart (STAH), the only FDA and Health Canada-approved total artificial heart for patients awaiting donor hearts. The company also develops the Emperor System, a fully implantable artificial heart designed to eliminate external drivers.